Disease modeling studies using induced pluripotent stem cells: Are we using enough controls?

Adiv A. Johnson, Cynthia Andrews-Pfannkoch, Timothy J Nelson, Jose S Pulido, Alan D Marmorstein

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The comparison of differentiated induced pluripotent stem cells (iPSCs) derived from patients with disease to differentiated iPSCs derived from healthy patients enables powerful disease modeling. By performing an informal retrospective survey of disease modeling studies published in high impact journals, we found that the median and average number of controls used in these studies were 1 and 1.6, respectively. The bulk of these studies did not control for age, gender and ethnicity. Since a large proportion of phenotypic differences observed between iPSC lines are due to genetic variation or variation between lines, this is an insufficient number of controls to confidently rule out standard variation. Future studies need to include more controls and ensure that these controls are appropriately matched for gender, age and ethnicity.

Original languageEnglish (US)
Pages (from-to)899-903
Number of pages5
JournalRegenerative Medicine
Volume12
Issue number8
DOIs
StatePublished - Dec 1 2017

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Cell Line

Keywords

  • differentiation
  • disease modeling
  • disease-in-a-dish
  • embryonic stem cells
  • genetic variability
  • induced pluripotent stem cells
  • iPSC
  • reprogramming
  • stem cells

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Disease modeling studies using induced pluripotent stem cells : Are we using enough controls? / Johnson, Adiv A.; Andrews-Pfannkoch, Cynthia; Nelson, Timothy J; Pulido, Jose S; Marmorstein, Alan D.

In: Regenerative Medicine, Vol. 12, No. 8, 01.12.2017, p. 899-903.

Research output: Contribution to journalReview article

@article{458c6f5a2c2244e3a42645d7d166d3fc,
title = "Disease modeling studies using induced pluripotent stem cells: Are we using enough controls?",
abstract = "The comparison of differentiated induced pluripotent stem cells (iPSCs) derived from patients with disease to differentiated iPSCs derived from healthy patients enables powerful disease modeling. By performing an informal retrospective survey of disease modeling studies published in high impact journals, we found that the median and average number of controls used in these studies were 1 and 1.6, respectively. The bulk of these studies did not control for age, gender and ethnicity. Since a large proportion of phenotypic differences observed between iPSC lines are due to genetic variation or variation between lines, this is an insufficient number of controls to confidently rule out standard variation. Future studies need to include more controls and ensure that these controls are appropriately matched for gender, age and ethnicity.",
keywords = "differentiation, disease modeling, disease-in-a-dish, embryonic stem cells, genetic variability, induced pluripotent stem cells, iPSC, reprogramming, stem cells",
author = "Johnson, {Adiv A.} and Cynthia Andrews-Pfannkoch and Nelson, {Timothy J} and Pulido, {Jose S} and Marmorstein, {Alan D}",
year = "2017",
month = "12",
day = "1",
doi = "10.2217/rme-2017-0101",
language = "English (US)",
volume = "12",
pages = "899--903",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "8",

}

TY - JOUR

T1 - Disease modeling studies using induced pluripotent stem cells

T2 - Are we using enough controls?

AU - Johnson, Adiv A.

AU - Andrews-Pfannkoch, Cynthia

AU - Nelson, Timothy J

AU - Pulido, Jose S

AU - Marmorstein, Alan D

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The comparison of differentiated induced pluripotent stem cells (iPSCs) derived from patients with disease to differentiated iPSCs derived from healthy patients enables powerful disease modeling. By performing an informal retrospective survey of disease modeling studies published in high impact journals, we found that the median and average number of controls used in these studies were 1 and 1.6, respectively. The bulk of these studies did not control for age, gender and ethnicity. Since a large proportion of phenotypic differences observed between iPSC lines are due to genetic variation or variation between lines, this is an insufficient number of controls to confidently rule out standard variation. Future studies need to include more controls and ensure that these controls are appropriately matched for gender, age and ethnicity.

AB - The comparison of differentiated induced pluripotent stem cells (iPSCs) derived from patients with disease to differentiated iPSCs derived from healthy patients enables powerful disease modeling. By performing an informal retrospective survey of disease modeling studies published in high impact journals, we found that the median and average number of controls used in these studies were 1 and 1.6, respectively. The bulk of these studies did not control for age, gender and ethnicity. Since a large proportion of phenotypic differences observed between iPSC lines are due to genetic variation or variation between lines, this is an insufficient number of controls to confidently rule out standard variation. Future studies need to include more controls and ensure that these controls are appropriately matched for gender, age and ethnicity.

KW - differentiation

KW - disease modeling

KW - disease-in-a-dish

KW - embryonic stem cells

KW - genetic variability

KW - induced pluripotent stem cells

KW - iPSC

KW - reprogramming

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=85038628628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038628628&partnerID=8YFLogxK

U2 - 10.2217/rme-2017-0101

DO - 10.2217/rme-2017-0101

M3 - Review article

VL - 12

SP - 899

EP - 903

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 8

ER -